EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS

TENAILLON A DHAINAUT JF LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP CHRETIEN JM LAVERGNE V GUINOT P

A. Tenaillon et al., EFFICACY OF PAF ANTAGONIST (BN-52021) IN REDUCING MORTALITY OF PATIENTS WITH SEVERE GRAM-NEGATIVE SEPSIS, The American review of respiratory disease, 147(4), 1993, pp. 97-97

1

Respiratory System

The American review of respiratory disease → ACNP

00030805

147

4

1993

S

97 - 97

ISI

0003-0805(1993)147:4<97:EOPA(I>2.0.ZU;2-L